Read More Pharma Industry News Eli Lilly’s tirzepatide shows promising results in MASH treatment study Eli Lilly and Company (NYSE: LLY) revealed compelling outcomes from the SYNERGY-NASH study, showcasing significant efficacy of tirzepatide… byPallavi MadhirajuJune 9, 2024